$CBIO 3 SEC Filings

Filed On	Filing
15 Jul 2025	Form 3: Pinkas Jan, Chief Scientific Officer No securities owned
30 Jun 2025	Form 3: Im Ellie Eunkyung, Chief Medical Officer
30 Jun 2025	Form 3: Bispham Barbara Harlin, See Remarks
23 Jun 2025	Form 3: Lynch Ryan, See Remarks
23 Jun 2025	Form 3: Doughty Christopher Grant, Chief Business Officer Holds 39,480 shares of Ordinary Shares
23 Jun 2025	Form 3: Scalzo Richard William, Chief Financial Officer
23 Jun 2025	Form 3: McNeill Jonathan, See Remarks Holds 134,200 shares of Ordinary Shares
23 Jun 2025	Form 3: Brumm Joshua T, Director Holds 268,400 shares of Ordinary Shares
23 Jun 2025	Form 3: Fairmount Funds Management Llc, Director and 3 others Holds 1,387,866 shares of Ordinary Shares
23 Jun 2025	Form 3: Lubner David Charles, Director
23 Jun 2025	Form 3: Violin Jonathan, Director Holds 69,515 shares of Ordinary Shares
23 Jun 2025	Form 3: Balcom Alexandra, Director
23 Jun 2025	Form 3: Moran Susan, Director
29 Jul 2024	Form 3: Siren, L.l.c., 10% owner and 2 others Holds 8,589,064 shares of Common Stock
31 Mar 2023	Form 3: Rath Chinmaya, SVP and Chief Business Officer Holds 161,178 shares of Common Stock
31 Mar 2023	Form 3: Johnson Bruce S, SVP & Chief Commercial Officer Holds 125,480 shares of Common Stock
13 Feb 2023	Form 3: Invus Public Equities, L.p., 10% owner and 7 others Holds 6,562,347 shares of Common Stock
07 Sep 2022	Form 3: Rock Edwin, Chief Medical Officer Holds 0 shares of No securities beneficially owned
10 Aug 2021	Form 3: Semerjian Harout, Director Holds 0 shares of No securities beneficially owned
08 Mar 2021	Form 3: Feldman Eric Jay, Chief Medical Officer Holds 50,498 shares of Common Stock

Comments